SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-17-002807
Filing Date
2017-06-13
Accepted
2017-06-13 16:58:56
Documents
3
Period of Report
2017-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctxr_8k.htm 8-K 15289
2 RELEASE AGREEMENT ctxr_ex101.htm EX-10.1 8586
3 FORM OF RELEASE AGREEMENT ctxr_ex102.htm EX-10.2 10683
  Complete submission text file 0001477932-17-002807.txt   35934
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55532 | Film No.: 17909446
SIC: 2834 Pharmaceutical Preparations